Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

135.87
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
95.08
Today|||52-Week Range
149.31
+33.72%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 154.00, with a high estimate of 170.00 and a low estimate of 105.00. The median estimate represents a +13.34% increase from the last price of 135.87.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.05
Sales
$45.2M
Reporting Date
Feb 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 51.59%
 
 
 
 
 
 
Growthannually 38.70%
 
 
 
 
 
 

Sales

Growthquarterly 35.36%
 
 
 
 
 
 
Growthannually 24.54%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.